Microbix Biosystems (MBX) Stock Price, News & Analysis

Company Overview

Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows.

Key Stats

• Today's Range: C$0.23 to C$0.24
• 50-Day Range: C$0.23 to C$0.31
• 52-Week Range: C$0.23 to C$0.55
• Volume: 614,815 shs
• Average Volume: 136,260 shs
• Market Capitalization: C$32.96 million
• P/E Ratio: N/A
• Dividend Yield: 2.30%
• Price Target: N/A
• Consensus Rating: N/A

MBX Stock Analysis - Frequently Asked Questions

How have MBX shares performed this year?

Microbix Biosystems' stock was trading at C$0.41 on January 1st, 2025. Since then, MBX stock has decreased by 42.7% and is now trading at C$0.24.

How do I buy shares of Microbix Biosystems?

Shares of MBX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Microbix Biosystems own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Microbix Biosystems investors own include TransAlta Renewables (RNW), Moderna (MRNA), Canopy Growth (CGC), NightHawk Biosciences (NHWK), Organigram (OGI), VEON (VEON) and Vaxart (VXRT).

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: TSE:MBX
• CIK: N/A
• Web: microbix.com
• Phone: +1-905-3618910
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): C$0.00
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 11.75
• P/E Growth: N/A
• Net Income: C$3.39 million
• Net Margins: 13.86%
• Pretax Margin: N/A
• Return on Equity: 12.65%
• Return on Assets: 3.82%

Debt

• Debt-to-Equity Ratio: 22.61
• Current Ratio: 7.15
• Quick Ratio: 5.57

Sales & Book Value

• Annual Sales: C$21.13 million
• Price / Sales: 1.56
• Cash Flow: C$0.06 per share
• Price / Cash Flow: 4.13
• Book Value: C$0.21 per share
• Price / Book: 1.14

Miscellaneous

• Outstanding Shares: 140,260,000
• Free Float: N/A
• Market Cap: C$32.96 million
• Optionable: Not Optionable
• Beta: 0.12